ARYX THERAPEUTICS Stock Financials

ARYX
 Stock
  

USD 0.0005  0.00  0.00%   

We suggest to use ARYX THERAPEUTICS INC fundamental analysis to find out if markets are now mispricing the company. Put another way you can use it to find out if ARYX THERAPEUTICS INC is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We have analyzed and interpolated thirty available fundamental indicators for ARYX THERAPEUTICS INC, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all ARYX THERAPEUTICS INC financials, including its current ratio, as well as the relationship between the beta and current liabilities . As ARYX THERAPEUTICS INC appears to be a penny stock we also recommend to validate its price to sales numbers. Use ARYX THERAPEUTICS to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of ARYX THERAPEUTICS to be traded at $5.0E-4 in 90 days.
  
With this module, you can analyze ARYX THERAPEUTICS financials for your investing period. You should be able to track the changes in ARYX THERAPEUTICS individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

ARYX THERAPEUTICS Most Recent Estimates

Diluted Eps
(0.59) 
Earnings Share
(0.59) 
Understanding current and past ARYX THERAPEUTICS Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ARYX THERAPEUTICS's financial statements are interrelated, with each one affecting the others. For example, an increase in ARYX THERAPEUTICS's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Over 97
ARYX THERAPEUTICS INC has more than 97 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for ARYX THERAPEUTICS stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in ARYX THERAPEUTICS's official financial statements usually reflect ARYX THERAPEUTICS's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ARYX THERAPEUTICS INC. For example, before you start analyzing numbers published by ARYX THERAPEUTICS accountants, it's critical to develop an understanding of what ARYX THERAPEUTICS's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of ARYX THERAPEUTICS's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ARYX THERAPEUTICS's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ARYX THERAPEUTICS's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ARYX THERAPEUTICS INC. Please utilize our Beneish M Score to check the likelihood of ARYX THERAPEUTICS's management to manipulate its earnings.

ARYX THERAPEUTICS Company Summary

ARYX THERAPEUTICS competes with Bright Lights. ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. ARYX THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 56 people.
InstrumentUSA Stock View All
ExchangePNK Exchange
Business Address6300 Dumbarton Circle
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic
BenchmarkDOW
Websitewww.aryx.com
Phone510 585 2200
CurrencyUSD - US Dollar
You should never invest in ARYX THERAPEUTICS without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ARYX THERAPEUTICS Stock, because this is throwing your money away. Analyzing the key information contained in ARYX THERAPEUTICS's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

ARYX THERAPEUTICS Key Financial Ratios

Generally speaking, ARYX THERAPEUTICS's financial ratios allow both analysts and investors to convert raw data from ARYX THERAPEUTICS's financial statements into concise, actionable information that can be used to evaluate the performance of ARYX THERAPEUTICS over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ARYX THERAPEUTICS INC reports annually and quarterly.

ARYX THERAPEUTICS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ARYX THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare ARYX THERAPEUTICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ARYX THERAPEUTICS competition to find correlations between indicators driving ARYX THERAPEUTICS's intrinsic value. More Info.
ARYX THERAPEUTICS INC is number one stock in number of employees category among related companies. It is number one stock in number of shares shorted category among related companies making about  1,590  of Number of Shares Shorted per Number of Employees. . Comparative valuation analysis is a catch-all model that can be used if you cannot value ARYX THERAPEUTICS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ARYX THERAPEUTICS's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ARYX THERAPEUTICS's earnings, one of the primary drivers of an investment's value.

ARYX THERAPEUTICS INC Systematic Risk

ARYX THERAPEUTICS's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ARYX THERAPEUTICS volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on ARYX THERAPEUTICS INC correlated with the market. If Beta is less than 0 ARYX THERAPEUTICS generally moves in the opposite direction as compared to the market. If ARYX THERAPEUTICS Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ARYX THERAPEUTICS INC is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ARYX THERAPEUTICS is generally in the same direction as the market. If Beta > 1 ARYX THERAPEUTICS moves generally in the same direction as, but more than the movement of the benchmark.
.

About ARYX THERAPEUTICS Financials

What exactly are ARYX THERAPEUTICS Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include ARYX THERAPEUTICS's income statement, its balance sheet, and the statement of cash flows. Potential ARYX THERAPEUTICS investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although ARYX THERAPEUTICS investors may use each financial statement separately, they are all related. The changes in ARYX THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ARYX THERAPEUTICS's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as ARYX THERAPEUTICS is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of ARYX THERAPEUTICS has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
Please continue to Trending Equities. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for analysis

When running ARYX THERAPEUTICS INC price analysis, check to measure ARYX THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARYX THERAPEUTICS is operating at the current time. Most of ARYX THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ARYX THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ARYX THERAPEUTICS's price. Additionally, you may evaluate how the addition of ARYX THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is ARYX THERAPEUTICS's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ARYX THERAPEUTICS. If investors know ARYX THERAPEUTICS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ARYX THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
237.6 K
Return On Assets
(0.75) 
The market value of ARYX THERAPEUTICS INC is measured differently than its book value, which is the value of ARYX THERAPEUTICS that is recorded on the company's balance sheet. Investors also form their own opinion of ARYX THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is ARYX THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARYX THERAPEUTICS's market value can be influenced by many factors that don't directly affect ARYX THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARYX THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine ARYX THERAPEUTICS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARYX THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.